Bio-rad Laboratories, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE

14 Feb 2025

BIO

10-K: Bio-Rad Laboratories Reports Significant Losses Due to Sartorius AG Valuation, Announces Restructuring

Bio-Rad Laboratories' 2024 results were significantly impacted by losses from changes in the fair market value of its investment in Sartorius AG, leading to a substantial net loss, while the company also announced a restructuring plan to improve operating performance.

NYSE

16 Feb 2024

BIO

Bio-rad Laboratories, INC

10-K: Bio-Rad Laboratories Reports Full Year 2023 Results Amidst Economic Headwinds and Strategic Restructuring

Bio-Rad Laboratories experienced a decrease in net sales for 2023, impacted by global economic conditions and biopharma market constraints, while also navigating strategic restructuring efforts.